ABCELLERA BIOLOGICS

abcellera-biologics-logo

AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics.

#SimilarOrganizations #People #Financial #Event #More

ABCELLERA BIOLOGICS

Social Links:

Industry:
Biotechnology Medical Therapeutics

Founded:
2012-01-01

Status:
Active

Contact:
(604) 559-9005

Total Funding:
371.22 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Amazon IPv6 Google Apps For Business Microsoft Azure DNS


Similar Organizations

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.


Current Advisors List

john-hamer_image

John Hamer Board of Director @ AbCellera Biologics
Board_member

Current Employees Featured

kevin-heyries_image

Kevin Heyries
Kevin Heyries Co-Founder, Head of Business Development @ AbCellera Biologics
Co-Founder, Head of Business Development
2017-01-01

carl-hansen_image

Carl Hansen
Carl Hansen CEO @ AbCellera Biologics
CEO

véronique-lecault_image

Véronique Lecault
Véronique Lecault Co-Founder @ AbCellera Biologics
Co-Founder
2012-12-01

jake-beverage_image

Jake Beverage
Jake Beverage Vice President, Alliance Management @ AbCellera Biologics
Vice President, Alliance Management
2021-11-01

véronique-lecault_image

Véronique Lecault
Véronique Lecault Chief Operating Officer @ AbCellera Biologics
Chief Operating Officer
2019-09-01

véronique-lecault_image

Véronique Lecault
Véronique Lecault Corporate Development @ AbCellera Biologics
Corporate Development
2017-01-01

anne-stevens_image

Anne Stevens
Anne Stevens Head of Business Partnering @ AbCellera Biologics
Head of Business Partnering
2020-11-01

bryan-barnhart_image

Bryan Barnhart
Bryan Barnhart Scientific Director @ AbCellera Biologics
Scientific Director
2020-01-01

not_available_image

Neil Berkley
Neil Berkley Chief Business Officer @ AbCellera Biologics
Chief Business Officer
2021-07-01

Founder


carl-hansen_image

Carl Hansen

kevin-heyries_image

Kevin Heyries

véronique-lecault_image

Véronique Lecault

Stock Details


Company's stock symbol is NASDAQ:ABCL

Acquisitions List

Date Company Article Price
2021-09-13 Tetragenetics Tetragenetics acquired by AbCellera Biologics N/A
2020-11-18 Trianni Trianni acquired by AbCellera Biologics 90 M USD
2020-08-20 Dualogics - OrthoMab Dualogics - OrthoMab acquired by AbCellera Biologics N/A
2018-08-01 Lineage Biosciences Lineage Biosciences acquired by AbCellera Biologics N/A

Investors List

eli-lilly_image

Eli Lilly

Eli Lilly investment in Series B - AbCellera Biologics

presight-capital_image

Presight Capital

Presight Capital investment in Series B - AbCellera Biologics

founders-fund_image

Founders Fund

Founders Fund investment in Series B - AbCellera Biologics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - AbCellera Biologics

data-collective_image

DCVC

DCVC investment in Series B - AbCellera Biologics

peter-thiel_image

Peter Thiel

Peter Thiel investment in Series B - AbCellera Biologics

viking-global-investors_image

Viking Global Investors

Viking Global Investors investment in Series B - AbCellera Biologics

university-of-minnesota_image

University of Minnesota

University of Minnesota investment in Series B - AbCellera Biologics

government-of-canada_image

Government of Canada

Government of Canada investment in Grant - AbCellera Biologics

founders-fund_image

Founders Fund

Founders Fund investment in Series A - AbCellera Biologics

Investments List

Date Company Article Money raised
2020-09-30 Invetx AbCellera Biologics investment in Series A - Invetx 10.25 M USD
2020-02-24 Invetx AbCellera Biologics investment in Series A - Invetx 15 M USD

Key Employee Changes

Date New article
2021-07-13 AbCellera Appoints Neil Berkley as Chief Business Officer

More informations about "AbCellera Biologics" on Search Engine